INSP Intrinsic Value Calculator – INSPIRE MEDICAL SYSTEMS Wins FDA Approval for Expanded Labeling of Sleep Apnea Device
June 18, 2023
☀️Trending News
INSPIRE MEDICAL SYSTEMS ($NYSE:INSP) is a medical technology company that specializes in the treatment of sleep apnea and other sleep-disordered breathing conditions. The company has recently won the approval of the US Food and Drug Administration for an expanded labeling for their sleep apnea device. This will allow patients who have been diagnosed with moderate to severe obstructive sleep apnea to receive the treatment. The device works by stimulating the hypoglossal nerve, which helps to keep the airway open while the patient is sleeping.
This minimizes snoring and sleep apnea symptoms such as gasping for breath and choking at night. The device is an implantable technology that is inserted through the neck and placed near the carotid artery. This technology has been proven to significantly reduce sleep apnea symptoms, improving sleep quality and overall quality of life for patients with the condition.
Price History
The news caused an immediate rise in their stock prices, with the stock opening at $311.1 and closing at $307.0, representing a 0.6% decrease from the previous closing price of $308.8. With the FDA approval, INSPIRE MEDICAL SYSTEMS is now able to bring a revolutionary sleep apnea management system to those suffering from the most severe forms of the condition. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for INSP. More…
| Total Revenues | Net Income | Net Margin |
| 466.37 | -43.61 | -9.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for INSP. More…
| Operations | Investing | Financing |
| 11.57 | -19.6 | 235.08 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for INSP. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 571.85 | 67.2 | 17.32 |
Key Ratios Snapshot
Some of the financial key ratios for INSP are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 74.9% | – | -8.9% |
| FCF Margin | ROE | ROA |
| 0.5% | -5.2% | -4.6% |
Analysis – INSP Intrinsic Value Calculator
GoodWhale has conducted an analysis of INSPIRE MEDICAL SYSTEMS’ wellbeing and determined that the fair value of their share is around $409.1. This figure was calculated using our proprietary Valuation Line, taking into account the company’s financials, macroeconomic information, the overall market, and other important factors. Our analysis shows that the current price of INSPIRE MEDICAL SYSTEMS stock (at $307.0) is undervalued by 25.0%. This presents an excellent opportunity for investors looking to buy a stake in this company. More…
Peers
The company’s competitors include ShockWave Medical Inc, InMode Ltd, and INVO Bioscience Inc.
– ShockWave Medical Inc ($NASDAQ:SWAV)
ShockWave Medical Inc is a medical device company that uses shockwave technology to treat cardiovascular disease. The company has a market cap of 9.73B as of 2022 and a return on equity of 19.56%. The company’s products are used to treat a variety of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and heart failure.
– InMode Ltd ($NASDAQ:INMD)
InMode Ltd is a medical technology company that develops and manufactures minimally invasive aesthetic solutions. The company has a market capitalization of $2.71 billion as of 2022 and a return on equity of 41.58%. InMode’s products are used by physicians and patients in over 90 countries and the company has a strong presence in the United States, Europe, Asia, and Latin America. InMode’s products are backed by clinical research and have been featured in numerous peer-reviewed journals.
– INVO Bioscience Inc ($NASDAQ:INVO)
INVO Bioscience Inc is a medical device company that has developed a patented in vivo intravaginal culture (IVC) system, which is used to treat infertility. The company’s IVC system is designed to provide a more natural environment for embryo development and is intended to improve the success rates of in vitro fertilization (IVF). INVO Bioscience’s IVC system is currently being used at fertility clinics in the United States and Europe.
Summary
Inspire Medical Systems, Inc. (NYSE:INSP) is an innovative medical technology company that recently received expanded labeling from the Food and Drug Administration (FDA) for its implantable sleep apnea device. This expanded labeling is expected to significantly increase the company’s product reach and may result in higher revenues. The device offers a minimally-invasive treatment option for sleep apnea sufferers by targeting the root cause of the disorder. It is also designed to provide improved efficacy and safety while being highly cost-effective.
Investing in Inspire Medical Systems may present investors with an opportunity to capitalize on the potential for strong long-term prospects. The company has a strong balance sheet, experienced leadership, and a comprehensive product portfolio that could create significant growth potential for investors.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
